The prenatal screening laboratory already detect these markers (AFP and free β-hCG) as part of routine antenatal screening for chromosomal and neural tube defects, so it does not add to overall healthcare cost, yet it might provide prognostic information about potential development of HDP in the pregnancy. Here, AFP is linked to isolated spina bifida.